Trial Profile
Phase I pharmacokinetic trial of tivantinib: Absorption, distribution, metabolism, and excretion of 14C-labelled tivantinib in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2012
Price :
$35
*
At a glance
- Drugs Tivantinib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors ArQule
- 31 Mar 2012 New trial record
- 29 Mar 2012 Results will be presented at AACR-2012 according to an ArQule media release.